dc.contributor.author | Crabbé, F. | en_US |
dc.contributor.author | Grobbelaar, T. M. | en_US |
dc.contributor.author | Van Dyck, E. | en_US |
dc.contributor.author | Dangor, Y. | en_US |
dc.contributor.author | Laga, M. | en_US |
dc.contributor.author | Ballard, R. C. | en_US |
dc.date.accessioned | 2010-04-01T16:59:09Z | |
dc.date.available | 2010-04-01T16:59:09Z | |
dc.date.issued | 1997 | en_US |
dc.identifier.issn | 0266-4348 | en_US |
dc.identifier.other | ITG-M1A | en_US |
dc.identifier.other | ITG-M3A | en_US |
dc.identifier.other | ITG-M5A | en_US |
dc.identifier.other | MICRO | en_US |
dc.identifier.other | U-HIVSTD | en_US |
dc.identifier.other | JIF | en_US |
dc.identifier.other | en_US | |
dc.identifier.other | FTA | |
dc.identifier.uri | http://hdl.handle.net/10390/5306 | |
dc.language | English | en_US |
dc.subject | Bacterial diseases | en_US |
dc.subject | Gonorrhea | en_US |
dc.subject | Neisseria gonorrhoeae | en_US |
dc.subject | Drug sensitivity testing | en_US |
dc.subject | Drug resistance | en_US |
dc.subject | Urethritis | en_US |
dc.subject | Urology | en_US |
dc.subject | Cefaclor | en_US |
dc.subject | Cephalosporins | en_US |
dc.subject | South Africa | en_US |
dc.subject | Africa, Southern | en_US |
dc.title | Cefaclor, an alternative to third generation cephalosporins for the treatment of gonococcal urethritis in the developing world? | en_US |
dc.type | Article | en_US |
dc.citation.jtitle | Genitourinary Medicine | en_US |
dc.citation.volume | 73 | en_US |
dc.citation.pages | 506-509 | en_US |
dc.citation.jabbreviation | Genitourin Med | en_US |